BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31059194)

  • 1. A genetic variant in PIK3R1 is associated with pancreatic cancer survival in the Chinese population.
    Zhu Y; Ke J; Gong Y; Yang Y; Peng X; Tian J; Zou D; Yang N; Wang X; Mei S; Rao M; Ying P; Deng Y; Wang H; Zhang H; Li B; Wan H; Li Y; Niu S; Cai Y; Zhang M; Lu Z; Zhong R; Miao X; Chang J
    Cancer Med; 2019 Jul; 8(7):3575-3582. PubMed ID: 31059194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of cholecystokinin-B receptor genotype between patients with pancreatic cancer and controls and its impact on survival.
    Smith JP; Whitcomb DC; Matters GL; Brand RE; Liao J; Huang YJ; Frazier ML
    Pancreas; 2015 Mar; 44(2):236-42. PubMed ID: 25469546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study.
    Tang H; Wei P; Chang P; Li Y; Yan D; Liu C; Hassan M; Li D
    Int J Cancer; 2017 Aug; 141(4):678-686. PubMed ID: 28470677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1 missense polymorphisms are associated with poor prognosis of pancreatic cancer patients in a Chinese population.
    Zhu Y; Zhai K; Ke J; Li J; Gong Y; Yang Y; Tian J; Zhang Y; Zou D; Peng X; Gong J; Zhong R; Huang K; Chang J; Miao X
    Oncotarget; 2017 May; 8(22):36033-36039. PubMed ID: 28415599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide association study of survival in patients with pancreatic adenocarcinoma.
    Wu C; Kraft P; Stolzenberg-Solomon R; Steplowski E; Brotzman M; Xu M; Mudgal P; Amundadottir L; Arslan AA; Bueno-de-Mesquita HB; Gross M; Helzlsouer K; Jacobs EJ; Kooperberg C; Petersen GM; Zheng W; Albanes D; Boutron-Ruault MC; Buring JE; Canzian F; Cao G; Duell EJ; Elena JW; Gaziano JM; Giovannucci EL; Hallmans G; Hutchinson A; Hunter DJ; Jenab M; Jiang G; Khaw KT; LaCroix A; Li Z; Mendelsohn JB; Panico S; Patel AV; Qian ZR; Riboli E; Sesso H; Shen H; Shu XO; Tjonneland A; Tobias GS; Trichopoulos D; Virtamo J; Visvanathan K; Wactawski-Wende J; Wang C; Yu K; Zeleniuch-Jacquotte A; Chanock S; Hoover R; Hartge P; Fuchs CS; Lin D; Wolpin BM
    Gut; 2014 Jan; 63(1):152-60. PubMed ID: 23180869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants of the peroxisome proliferator-activated receptor (PPAR) signaling pathway genes and risk of pancreatic cancer.
    Liu X; Qian D; Liu H; Abbruzzese JL; Luo S; Walsh KM; Wei Q
    Mol Carcinog; 2020 Aug; 59(8):930-939. PubMed ID: 32367578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants.
    Dimitrakopoulos C; Vrugt B; Flury R; Schraml P; Knippschild U; Wild P; Hoerstrup S; Henne-Bruns D; Wuerl P; Graf R; Breitenstein S; Bond G; Beerenwinkel N; Grochola LF
    JAMA Surg; 2019 Jun; 154(6):e190484. PubMed ID: 30942874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
    Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A low-frequency variant in SMAD7 modulates TGF-β signaling and confers risk for colorectal cancer in Chinese population.
    Li J; Zou L; Zhou Y; Li L; Zhu Y; Yang Y; Gong Y; Lou J; Ke J; Zhang Y; Tian J; Zou D; Peng X; Chang J; Gong J; Zhong R; Zhou X; Miao X
    Mol Carcinog; 2017 Jul; 56(7):1798-1807. PubMed ID: 28218435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three novel genetic variants in NRF2 signaling pathway genes are associated with pancreatic cancer risk.
    Yang W; Liu H; Duan B; Xu X; Carmody D; Luo S; Walsh KM; Abbruzzese JL; Zhang X; Chen X; Wei Q
    Cancer Sci; 2019 Jun; 110(6):2022-2032. PubMed ID: 30972876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between ABO blood groups and pancreatic ductal adenocarcinoma: influence on resection status and survival.
    El Jellas K; Hoem D; Hagen KG; Kalvenes MB; Aziz S; Steine SJ; Immervoll H; Johansson S; Molven A
    Cancer Med; 2017 Jul; 6(7):1531-1540. PubMed ID: 28556564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exome-wide analysis identifies three low-frequency missense variants associated with pancreatic cancer risk in Chinese populations.
    Chang J; Tian J; Zhu Y; Zhong R; Zhai K; Li J; Ke J; Han Q; Lou J; Chen W; Zhu B; Shen N; Zhang Y; Gong Y; Yang Y; Zou D; Peng X; Zhang Z; Zhang X; Huang K; Yang M; Wang L; Wu C; Lin D; Miao X
    Nat Commun; 2018 Sep; 9(1):3688. PubMed ID: 30206226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants in AKT1 gene were associated with risk and survival of OSCC in Chinese Han Population.
    Wang Y; Lin L; Xu H; Li T; Zhou Y; Dan H; Jiang L; Liao G; Zhou M; Li L; Zeng X; Li J; Chen Q
    J Oral Pathol Med; 2015 Jan; 44(1):45-50. PubMed ID: 25060489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional variants of RPS6KB1 and PIK3R1 in the autophagy pathway genes and risk of bladder cancer.
    Ma L; Zhang D; Huang Z; Zheng R; Du M; Lv Q; Qin C; Chu H; Yuan L; Zhang Z
    Arch Toxicol; 2022 Jan; 96(1):367-375. PubMed ID: 34668023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K/Akt signaling pathway.
    Xu X; Yu Y; Zong K; Lv P; Gu Y
    J Exp Clin Cancer Res; 2019 Dec; 38(1):497. PubMed ID: 31852504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single nucleotide polymorphisms of genes for EGF, TGF-β and TNF-α in patients with pancreatic carcinoma.
    Zhang L; Wu G; Herrle F; Niedergethmann M; Keese M
    Cancer Genomics Proteomics; 2012; 9(5):287-95. PubMed ID: 22990108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CapG promotes resistance to paclitaxel in breast cancer through transactivation of PIK3R1/P50.
    Chi Y; Xue J; Huang S; Xiu B; Su Y; Wang W; Guo R; Wang L; Li L; Shao Z; Jin W; Wu Z; Wu J
    Theranostics; 2019; 9(23):6840-6855. PubMed ID: 31660072
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of Common Susceptibility Variants of Pancreatic Cancer in Higher-Risk Patients: A PACGENE Study.
    Childs EJ; Chaffee KG; Gallinger S; Syngal S; Schwartz AG; Cote ML; Bondy ML; Hruban RH; Chanock SJ; Hoover RN; Fuchs CS; Rider DN; Amundadottir LT; Stolzenberg-Solomon R; Wolpin BM; Risch HA; Goggins MG; Petersen GM; Klein AP
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1185-91. PubMed ID: 27197284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic alterations of K-ras, p53, c-erbB-2, and DPC4 in pancreatic ductal adenocarcinoma and their correlation with patient survival.
    Shin SH; Kim SC; Hong SM; Kim YH; Song KB; Park KM; Lee YJ
    Pancreas; 2013 Mar; 42(2):216-22. PubMed ID: 23344532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variants in PI3K/AKT pathway are associated with severe radiation pneumonitis in lung cancer patients treated with radiation therapy.
    Tang Y; Liu B; Li J; Wu H; Yang J; Zhou X; Yi M; Li Q; Yu S; Yuan X
    Cancer Med; 2016 Jan; 5(1):24-32. PubMed ID: 26645682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.